Cortisone Injection Market Overview
The Cortisone Injection Market is expanding as the prevalence of inflammatory and musculoskeletal conditions increases and demand for minimally invasive pain-management procedures grows. Rising cases of osteoarthritis and rheumatoid arthritis, a growing geriatric population, advancements in injection techniques, and expanding healthcare infrastructure are supporting market development.
According to the WiseGuyReports market report published in August 2024, the global Cortisone Injection Market was valued at USD 2.5 Billion in 2023 and USD 2.61 Billion in 2024 and is projected to reach USD 3.7 Billion by 2032, registering a CAGR of 4.45% during 2025–2032.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
https://www.wiseguyreports.com/sample-request?id=608949
Key players driving innovation and competitiveness in the Cortisone Injection Market include:
Teva Pharmaceutical Industries Ltd.
Hikma Pharmaceuticals PLC
Merck & Co., Inc.
Abbott Laboratories
Pfizer Inc.
Cipla Limited
Boehringer Ingelheim International GmbH
Novartis AG
Baxter International Inc.
Sun Pharmaceutical Industries Ltd.
Mylan N.V.
Biocon Limited
Bayer AG
Aspen Pharmacare Holdings Limited
The market is being shaped by the growing prevalence of rheumatic and musculoskeletal diseases, including osteoarthritis and rheumatoid arthritis. Cortisone injections are used to manage pain and inflammation associated with several conditions, while the increasing adoption of minimally invasive procedures is supporting demand.
Technological advancements are also creating opportunities for market development. Ultrasound and fluoroscopy are increasingly being used to guide injection procedures, while innovations such as extended-release formulations and targeted delivery systems are intended to improve treatment duration and precision.
The Cortisone Injection Market can be segmented by Injection Type into Intramuscular, Intra-articular, Intravenous, Intradermal, and Subcutaneous. By Route of Administration, it includes Injectable Suspensions and Injectable Solutions. By End User, it covers Hospitals and Clinics, Ambulatory Surgical Centers, Pain Management Centers, Rheumatology Clinics, and Orthopedic Clinics. By Application, it includes Osteoarthritis, Rheumatoid Arthritis, Psoriatic Arthritis, Bursitis, Tendonitis, Carpal Tunnel Syndrome, and Epicondylitis. By Cortisone Type, it covers Triamcinolone, Methylprednisolone, Prednisolone, Dexamethasone, and Betamethasone. Regionally, the market covers North America, Europe, South America, Asia Pacific, and the Middle East and Africa.
The Intramuscular segment accounted for more than 40% of global revenue in 2023, while Injectable Suspensions held a 65.1% market share in 2024. The osteoarthritis application was valued at USD 0.9 Billion in 2024, while Triamcinolone accounted for around 35.6% of global market revenue in 2023.
North America dominated the market in 2023, supported by a large patient population, established healthcare infrastructure, and the prevalence of chronic conditions. Asia Pacific is expected to witness the fastest growth during the forecast period as healthcare access expands and chronic disease prevalence increases.
Recent Developments and Market Trends:
The increasing prevalence of osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders is supporting demand for cortisone injections.
Growing adoption of minimally invasive procedures is creating opportunities for cortisone-based pain-management treatments.
Extended-release formulations are being developed to provide longer-lasting therapeutic effects and reduce injection frequency.
Ultrasound and fluoroscopy-guided injection techniques are improving the precision of treatment procedures.
Targeted delivery systems are creating opportunities to improve the effectiveness of cortisone injections.
The growing geriatric population is increasing demand for treatments addressing arthritis, chronic pain, and inflammatory conditions.
Asia Pacific is expected to experience strong growth as healthcare infrastructure and access to pain-management services continue to expand.
Reasons to Buy the Report:
Provides comprehensive insights into the Cortisone Injection Market dynamics, trends, opportunities, and growth potential.
Helps identify opportunities across injection types, routes of administration, applications, end users, cortisone types, and regional markets.
Offers detailed segmentation analysis covering major treatment applications and cortisone formulations.
Includes competitive intelligence covering leading pharmaceutical and healthcare companies.
Supports informed business decisions using market forecasts, technology developments, treatment trends, and regional opportunities.
Future Outlook:
The future of the Cortisone Injection Market will be shaped by the rising prevalence of musculoskeletal disorders, growing demand for minimally invasive procedures, an expanding geriatric population, and advancements in drug-delivery technologies. The global market is projected to increase from USD 2.61 Billion in 2024 to USD 3.7 Billion by 2032 at a CAGR of 4.45%. North America is expected to remain a significant regional market, while Asia Pacific is projected to experience strong growth as healthcare access and treatment capabilities continue to expand.
➤➤Explore Our Latest Related Reports:
